Goldman Sachs’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-200
| Closed | -$3K | – | 6733 |
|
|
2017
Q3 | $3K | Hold |
200
| – | – | ﹤0.01% | 6602 |
|
|
2017
Q2 | $3K | Sell |
200
-800
| -80% | -$12.2K | ﹤0.01% | 6720 |
|
|
2017
Q1 | $15K | Sell |
1,000
-100
| -9% | -$1.47K | ﹤0.01% | 6568 |
|
|
2016
Q4 | $14K | Buy |
1,100
+800
| +267% | +$10.2K | ﹤0.01% | 6719 |
|
|
2016
Q3 | $3K | Sell |
300
-1,700
| -85% | -$20.4K | ﹤0.01% | 6952 |
|
|
2016
Q2 | $24K | Sell |
2,000
-200
| -9% | -$2.69K | ﹤0.01% | 6664 |
|
|
2016
Q1 | $34K | Buy |
2,200
+800
| +57% | +$12.1K | ﹤0.01% | 6585 |
|
|
2015
Q4 | $23K | Sell |
1,400
-2,200
| -61% | -$32.1K | ﹤0.01% | 6815 |
|
|
2015
Q3 | $45K | Sell |
3,600
-4,300
| -54% | -$59K | ﹤0.01% | 6829 |
|
|
2015
Q2 | $131K | Buy |
7,900
+5,400
| +216% | +$87K | ﹤0.01% | 6459 |
|
|
2015
Q1 | $40K | Sell |
2,500
-4,200
| -63% | -$69.5K | ﹤0.01% | 6760 |
|
|
2014
Q4 | $104K | Sell |
6,700
-79,100
| -92% | -$1.16M | ﹤0.01% | 6558 |
|
|
2014
Q3 | $1.18M | Buy |
85,800
+75,700
| +750% | +$1.15M | ﹤0.01% | 4444 |
|
|
2014
Q2 | $162K | Buy |
10,100
+1,800
| +22% | +$28.5K | ﹤0.01% | 6347 |
|
|
2014
Q1 | $140K | Sell |
8,300
-25,700
| -76% | -$466K | ﹤0.01% | 6272 |
|
|
2013
Q4 | $716K | Buy |
34,000
+21,100
| +164% | +$475K | ﹤0.01% | 5024 |
|
|
2013
Q3 | $280K | Sell |
12,900
-30,000
| -70% | -$640K | ﹤0.01% | 5610 |
|
|
2013
Q2 | $803K | Buy |
+42,900
| New | +$782K | ﹤0.01% | 4568 |
|
Other funds holding NXGN
Goldman Sachs's NXGN Position: Q4 2023 in Review
Goldman Sachs sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 782,061 shares — an estimated $18.6M sold.
Goldman Sachs first reported a position in NXGN in Q2 2013 and held it in 42 quarters. The position peaked at $36M in Q1 2014. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.
- Goldman Sachs reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Goldman Sachs sold 782,061 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $18.6M.
- Goldman Sachs first reported a position in NextGen Healthcare, Inc. Common Stock in Q2 2013 and held it in 42 quarters.
- Goldman Sachs's NextGen Healthcare, Inc. Common Stock position peaked at $36M in Q1 2014.
- 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.
Based on Goldman Sachs's 13F filing for Q4 2023, filed 13 Feb 2024.